Physical Activity Intervention for Lung Cancer Survivors
The purpose of this study is to learn how many lung cancer survivors will agree to a physical activity program. We also want to know if lung cancer survivors benefit from this program. This information will help us to develop our services for lung cancer survivors.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Jun 7, 2023 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Observational
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Interventions being studied
- Behavioral: interview and physical activity; Behavioral: interview and wait list
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Diagnosis and treatment at MSKCC of primary NSCLC; and/or pulmonary carcinoid;
- At least one year post thoracic surgical resection;
- Have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any cancer treatment;
- Currently sedentary or insufficiently active, defined by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention as less than a total of 150 minutes of at least moderate intensity PA per week;
- Able to complete a six-minute walk test (6MWT);
- Able to provide informed consent. FOCUS GROUP ONLY:
- Completed the Physical Activity program offered through this study (08067);
- Presence of one of the following medical factors at screening:
- regular use of an ambulatory aid (cane or walker);
- resting oxygen saturation less than 88%;
- inability to walk due to severe arthritis or other musculoskeletal problems;
- a diagnosis of unstable angina in the previous 6 weeks;
- a heart attack, angioplasty or heart surgery in the previous 3 months;
- current heart rate \<50 or \>120 at rest; current uncontrolled hypertension;
- current significant valvular heart disease or decompensated congestive heart failure and
- patient reported pain of any origin that would preclude participation in the proposed PA intervention
- Evidence of significant medical cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in the intervention
- Self-reporting of greater than 60 minutes of vigorous activity per week or 150 minutes of moderate intensity PA per week.
- Patient resides at more than two hours travel distance from the Center
- Insufficient English fluency to complete evaluation tools.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 7, 2023. Always confirm current availability with the study team.